LTRX Rule 144 Notice: 22,993 Shares Valued at $114K Listed for Sale

Rhea-AI Filing Summary

Lantronix, Inc. (LTRX) Form 144 notice for proposed sale of securities. The filing reports an intended sale of 22,993 shares of common stock through Charles Schwab with an aggregate market value of $114,160.25, representing part of the issuer's 39,151,106 shares outstanding. The shares were acquired as compensation on 11/07/2023, and the approximate sale date is listed as 09/02/2025 on NASDAQ. The filer certifies no undisclosed material adverse information and reports no sales of the issuer's securities by the filer in the past three months.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice disclosing an insider/affiliate sale intent; not immediately material to company fundamentals.

The Form 144 documents a proposed sale of 22,993 shares acquired as compensation in November 2023, to be executed through Charles Schwab with an indicated transaction date of September 2, 2025. The disclosed aggregate value (~$114k) is small relative to the 39.15 million shares outstanding, so the transaction is unlikely to meaningfully dilute or alter market capitalization. No securities were sold by the filer in the prior three months, and the filer attests no undisclosed material information.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements; raises routine corporate governance transparency but no red flags.

The notice provides the required broker, share count, acquisition date, and nature of acquisition (compensation), and includes the standard signature attestation regarding material information. From a governance perspective, the filing demonstrates compliance with resale reporting obligations. There are no indications of accelerated insider selling, recent related sales, or atypical payment arrangements disclosed in the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	22993	114160.25	39151106	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/07/2023	Compensation	Issuer			22993	11/07/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by LTRX disclose?

The filing discloses a proposed sale of 22,993 common shares acquired as compensation on 11/07/2023, with an aggregate market value of $114,160.25.

When is the approximate sale date for the shares in the LTRX Form 144?

The Form 144 lists the approximate date of sale as 09/02/2025 and identifies Charles Schwab as the broker.

How many LTRX shares outstanding are noted in the Form 144?

The filing reports 39,151,106 shares outstanding of the issuer.

Was the acquisition of the shares a gift or compensation according to the filing?

The filing states the shares were acquired as compensation on 11/07/2023.

Did the filer sell any LTRX securities in the past three months?

The Form 144 indicates "Nothing to Report" under securities sold during the past three months.

Does the filer attest to possession of material nonpublic information in the Form 144?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.